US judge refuses to block Medicare from negotiating drug pri

(Reuters) -The U.S. government's Medicare health insurance program can begin negotiating prices for some prescription drugs this fall under a new program, a federal judge ruled on Friday, vindicating one of President Joe Biden's signature initiatives. The order by U.S. District Judge Michael Newman in Dayton, Ohio, comes in a lawsuit brought against the Biden administration by the U.S. Chamber of Commerce.

Related Keywords

Boston , Massachusetts , United States , New York , Ohio , Dayton , White House , District Of Columbia , Americans , America , American , Leslie Adler , Karine Jean Pierre , Alexia Garamfalvi , Joe Biden , Michael Newman , Bristol Myers , Chris Reese , Nate Raymond , Brendan Pierson , Donald Trump , Reuters , Us Justice Department , Us Chamber , Johnson , Medicaid Service , Merck Co , Pfizer , Us Centers For Medicare , Bristol Myers Squibb , Boehringer Ingelheim , President Joe Biden , Judge Michael Newman , Big Pharma , President Donald , Inflation Reduction Act , Pharmaceutical Research , Reporting By Brendan Pierson , Costas Pitas , Bill Berkrot , Medicare , Us Chamber Of Commerce , Price Negotiation , Chamber Of Commerce , Biden Administration , Drug Prices , Price Negotiation Program ,